The fight for justice continues for the thousands of women who developed ovarian cancer after using Johnson & Johnson’s talc-based products. With growing opposition to J&J’s $10 billion bankruptcy plan through the use of its Red River construct, the U.S. Trustee and multiple insurers have raised concerns over its "irregularities and fairness" —citing last year’s Supreme Court ruling in Purdue Pharma, which invalidated similar non-consensual releases.
Richard Golomb, of counsel to Anapol Weiss, was quoted in Law.com last week, noting that, “As we have been saying from the beginning of the Red River bankruptcy, the J&J plan and tactics, in an attempt to push it through over the objections of thousands and thousands of women, is fraught with irregularities and generally unfair.”*
With a key hearing set for Feb. 18, this case remains a critical fight for accountability and justice. At Anapol Weiss, we continue to stand with the women and families impacted, ensuring their voices are heard.
Read the Law.com article here: